2Seventy Bio Inc Conference Call Transcript
Good day, and thank you for standing by. Welcome to the 2seventy bio Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Liz Pingpank Hickin, Head of Investor Relations. Please go ahead.
Thank you, operator. This morning, 2seventy bio issued two press releases, providing business updates on our restructuring, as well as news regarding the expansion of our partnership with JW Therapeutics. The press releases can be found in the Investors and Media section of the company's website at 2seventybio.com.
Speaking on the call today are Nick Leschly, Chief Kairos Officer; Chip Baird, Chief Operating Officer; and Steve Bernstein, Chief Medical Officer; Philip Gregory, Chief Scientific Officer; and Susan Abu-Absi, Chief Technology Officer, are also on the line for the Q&A section.
As a reminder, today's discussion will include forward-looking statements related to 2seventy bio's current plans and expectations,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |